GlaxoSmithKline Pharmaceuticals has reported results for first quarter ended June 30, 2016.
The company has reported a fall of 23.13% in its net profit at Rs 72.27 crore for the quarter ended June 30, 2016 as compared to Rs 94.01 crore for the same quarter in the previous year. However, total income of the company increased by 5.46% to Rs 729.35 crore for the quarter under review, from Rs 691.58 crore for the corresponding quarter of the previous year.
GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.
